Evidence map›Paper›PMID 22351938›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2012

Essential role for CAML in follicular B cell survival and homeostasis.

Nicholas A Zane, Justin H Gundelach, Lonn D Lindquist, Richard J Bram

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Nicholas A ZaneDepartment of Immunology, College of Medicine, Mayo Clinic, Rochester, MN 55905, USA.
Justin H Gundelach
Lonn D Lindquist
Richard J Bram
Mayo Clinic in Arizona · USMayo Clinic · US

Funding

CAML in T cell Development and FunctionR01AI074320 · NIAID · MAYO CLINIC ROCHESTER · PI BRAM, RICHARD J · 2008 to 2011
$1.4M
CAML in T cell Development and FunctionR56AI074320 · NIAID · MAYO CLINIC ROCHESTER · PI BRAM, RICHARD J · 2007 to 2007
$340k
NIAID NIH HHS AI074320NIAID NIH HHS R01 AI074320NIAID NIH HHS R56 AI074320
6 · The paper itself

Abstract

Calcium-modulating cyclophilin ligand (CAML) is a ubiquitously expressed protein that is important during thymopoiesis. However, whether it serves a function in mature lymphocytes is unknown. In this article, we show that CAML is essential for survival of peripheral follicular (Fo) B cells. Conditional deletion of CAML in CD19-Cre transgenic mice caused a significant reduction in Fo cell numbers and increased rates of homeostatic proliferation. CAML-deficient Fo cells showed increased cellular turnover and normal proliferative ability. Although CAML-deficient Fo cells responded to AgR stimulation and to B cell activating factor, they displayed decreased survival and increased apoptosis following stimulation with LPS and IL-4 in vitro. Failure to survive was not due to aberrant B cell development in the absence of CAML, because induced deletion of the gene in mature cells resulted in a similar phenotype. These data establish an essential and ongoing role for CAML in the long-term survival of mature B cells.

Indexed as

Adaptor Proteins, Signal TransducingAdoptive TransferAnimalsApoptosisB-Cell Activating FactorB-Lymphocyte SubsetsCell SurvivalHomeostasisInterleukin-4LipopolysaccharidesLymph NodesMiceMice, Inbred NODMice, KnockoutMice, SCIDReceptors, Antigen, B-CellAdaptor Proteins, Signal TransducingB-Cell Activating FactorCaml protein, mouseInterleukin-4LipopolysaccharidesReceptors, Antigen, B-Cell

Identifiers

PMID22351938
PMCPMC3311719
OpenAlexW2104849211

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.